Cell therapy for cardiovascular diseases.
作者信息
Tateno Kaoru, Minamino Tohru, Moriya Junji, Katada Akemi, Yokoyama Masataka, Miura Kentaro, Komuro Issei
机构信息
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
出版信息
Ann Vasc Dis. 2008;1(2):66-79. doi: 10.3400/avd.AVDsr00108. Epub 2008 Oct 24.
Abstract
There have been great progresses in our knowledge of patho-physiology on various cardiovascular diseases, which enabled us to develop the field of regenerative medicine for previously untreatable patients. Among several strategies in cardiovascular regenerative medicine, cell transplantation is one of the best studied and the best clinically practiced. In this review we will first summarize the mechanisms of cell therapy, and then go through lists of cells and diseases that can be applied. Later we will introduce some of the clinical experiences published so far, with some discussion regarding the problems and perspectives of this novel therapeutics.
摘要
相似文献
1
Cell therapy for cardiovascular diseases.
Ann Vasc Dis. 2008;1(2):66-79. doi: 10.3400/avd.AVDsr00108. Epub 2008 Oct 24.
2
Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy.治疗性血管生成在儿童缺血性视网膜病变临床应用中的研究进展
J Lipid Atheroscler. 2020 May;9(2):268-282. doi: 10.12997/jla.2020.9.2.268. Epub 2020 May 18.
3
Extracorporeal shock wave therapy for ischemic cardiovascular disorders.体外冲击波治疗缺血性心血管疾病。
Am J Cardiovasc Drugs. 2011 Oct 1;11(5):295-302. doi: 10.2165/11592760-000000000-00000.
4
Application of hematopoietic cells to therapeutic angiogenesis.
Curr Pharm Des. 2006;12(5):557-63. doi: 10.2174/138161206775474332.
5
Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy.使用超声造影剂的分子成像：血管生成及细胞治疗的评估
Cardiovasc Res. 2009 Nov 1;84(2):190-200. doi: 10.1093/cvr/cvp248. Epub 2009 Jul 22.
6
Endothelial progenitor cells: therapeutic perspective for ischemic stroke.内皮祖细胞：缺血性脑卒中的治疗前景。
CNS Neurosci Ther. 2013 Feb;19(2):67-75. doi: 10.1111/cns.12040. Epub 2012 Dec 11.
7
8
Cardiovascular surgery for realization of regenerative medicine.用于实现再生医学的心血管外科手术。
Gen Thorac Cardiovasc Surg. 2012 Nov;60(11):744-55. doi: 10.1007/s11748-012-0139-7. Epub 2012 Aug 30.
9
Endothelial progenitor cell-based neovascularization: implications for therapy.基于内皮祖细胞的新生血管形成：对治疗的意义。
Trends Mol Med. 2009 Apr;15(4):180-9. doi: 10.1016/j.molmed.2009.02.001. Epub 2009 Mar 18.
10
Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.解决心血管疾病干细胞再生治疗主要临床障碍的潜在策略：综述。
JAMA Cardiol. 2016 Nov 1;1(8):953-962. doi: 10.1001/jamacardio.2016.2750.
引用本文的文献
1
Potential Clinical Implications of Senotherapies for Cardiovascular Disease.衰老疗法治疗心血管疾病的潜在临床意义。
Circ J. 2024 Feb 22;88(3):277-284. doi: 10.1253/circj.CJ-23-0657. Epub 2023 Oct 26.
2
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.衰老细胞：心血管疾病的治疗靶点。
Cells. 2023 May 2;12(9):1296. doi: 10.3390/cells12091296.
3
Angiogenesis, Cancer, and Vascular Aging.血管生成、癌症与血管衰老
Front Cardiovasc Med. 2017 Oct 24;4:65. doi: 10.3389/fcvm.2017.00065. eCollection 2017.
4
Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.接受自体单核细胞移植进行治疗性血管生成的严重肢体缺血患者的临床特征及预测因素
Heart Vessels. 2017 Sep;32(9):1099-1108. doi: 10.1007/s00380-017-0968-5. Epub 2017 Mar 29.
本文引用的文献
1
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.胰岛素样生长因子结合蛋白4是心脏发生所需的经典Wnt信号通路的抑制剂。
Nature. 2008 Jul 17;454(7202):345-9. doi: 10.1038/nature07027. Epub 2008 Jun 4.
2
Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart.宿主组织在缺血性心脏内皮祖细胞移植后产生持续体液效应中的作用。
J Exp Med. 2007 Dec 24;204(13):3257-69. doi: 10.1084/jem.20070166. Epub 2007 Dec 10.
3
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.通过特定因子将成人成纤维细胞诱导为多能干细胞。
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
4
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.p53诱导的Hif-1抑制在压力过载期间导致心脏功能障碍。
Nature. 2007 Mar 22;446(7134):444-8. doi: 10.1038/nature05602. Epub 2007 Mar 4.
5
Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.自体祖细胞移植用于严重肢体缺血患者治疗性血管生成的安全性和有效性。
Circ J. 2007 Feb;71(2):196-201. doi: 10.1253/circj.71.196.
6
Growth-factor-mediated cardiac stem cell activation in myocardial regeneration.生长因子介导的心肌再生中心脏干细胞激活
Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S46-51. doi: 10.1038/ncpcardio0772.
7
Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.间充质干细胞在心脏修复中的作用机制：对心脏干细胞微环境的潜在影响。
Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S21-6. doi: 10.1038/ncpcardio0770.
8
Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.血栓闭塞性脉管炎患者自体骨髓单个核细胞移植的非盲法初步研究。
Circulation. 2006 Dec 12;114(24):2679-84. doi: 10.1161/CIRCULATIONAHA.106.644203. Epub 2006 Dec 4.
9
Transcoronary transplantation of progenitor cells after myocardial infarction.心肌梗死后祖细胞的经冠状动脉移植
N Engl J Med. 2006 Sep 21;355(12):1222-32. doi: 10.1056/NEJMoa051779.
10
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.急性心肌梗死中的冠状动脉内骨髓源性祖细胞
N Engl J Med. 2006 Sep 21;355(12):1210-21. doi: 10.1056/NEJMoa060186.
Zotero 插件